ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD 0.2500
+0.0100 (4.17%)
Aug 24, 2026, 9:04 AM EST
ASEP Medical Holdings Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.12 | 0.15 | 0.02 | 0.06 | 2.13 | 5.29 |
Short-Term Investments | 0.16 | 0.14 | 0.03 | 0.16 | 1.15 | 0.39 |
Cash & Short-Term Investments | 0.28 | 0.29 | 0.05 | 0.23 | 3.28 | 5.68 |
Cash Growth | 261.39% | 536.62% | -79.75% | -93.13% | -42.19% | 1476.27% |
Other Receivables | 0.01 | 0.01 | 0.01 | 0.03 | 0.11 | 0.07 |
Receivables | 0.01 | 0.01 | 0.01 | 0.03 | 0.11 | 0.07 |
Total Current Assets | 0.3 | 0.3 | 0.06 | 0.25 | 3.4 | 5.75 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.02 | 0.04 | 0.05 | 0.06 |
Long-Term Investments | 1.56 | 1.51 | 2.46 | 2.38 | - | - |
Other Intangible Assets | 6.59 | 6.69 | 11.78 | 22.95 | 23.63 | 24.9 |
Total Assets | 8.65 | 8.72 | 14.32 | 25.61 | 27.08 | 30.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.13 | 1 | 1.61 | 0.43 | 0.48 | 0.14 |
Accrued Expenses | 0.99 | 0.87 | 0.89 | 0.25 | 0.05 | - |
Short-Term Debt | 0.27 | 0.22 | 0.31 | 0.02 | - | - |
Current Portion of Long-Term Debt | - | 0.03 | - | - | - | - |
Current Unearned Revenue | 0.22 | 0.3 | 0.3 | 0.3 | - | - |
Total Current Liabilities | 2.61 | 2.41 | 3.11 | 1 | 0.53 | 0.14 |
Long-Term Debt | 0.52 | 0.5 | - | - | - | - |
Long-Term Unearned Revenue | 1.46 | 1.46 | 1.76 | 2.06 | - | - |
Total Liabilities | 4.59 | 4.38 | 4.87 | 3.05 | 0.53 | 0.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 27.02 | 27.01 | 24.69 | 24.05 | 19.84 | 19.47 |
Additional Paid-In Capital | 3.51 | 3.51 | 2.44 | 2.81 | 2.11 | 0.96 |
Retained Earnings | -28.46 | -28.19 | -23.26 | -14.98 | -6.73 | -2.2 |
Comprehensive Income & Other | - | - | 1.07 | 0.74 | 0.24 | 0.04 |
Total Common Equity | 2.07 | 2.33 | 4.94 | 12.61 | 15.47 | 18.26 |
Minority Interest | 1.99 | 2.01 | 4.52 | 9.95 | 11.08 | 12.31 |
Shareholders' Equity | 4.06 | 4.34 | 9.46 | 22.56 | 26.55 | 30.57 |
Total Liabilities & Equity | 8.65 | 8.72 | 14.32 | 25.61 | 27.08 | 30.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.79 | 0.74 | 0.31 | 0.02 | - | - |
Net Cash (Debt) | -0.51 | -0.45 | -0.27 | 0.21 | 3.28 | 5.68 |
Net Cash Growth | - | - | - | -93.75% | -42.19% | - |
Net Cash Per Share | -0.05 | -0.04 | -0.04 | 0.03 | 0.58 | 2.66 |
Filing Date Shares Outstanding | 15.87 | 15.87 | 11.12 | 7.61 | 6.21 | 5.61 |
Total Common Shares Outstanding | 11.17 | 11.12 | 7.76 | 7.42 | 6.21 | 5.61 |
Working Capital | -2.31 | -2.11 | -3.05 | -0.74 | 2.87 | 5.61 |
Book Value Per Share | 0.19 | 0.21 | 0.64 | 1.70 | 2.49 | 3.25 |
Tangible Book Value | -4.52 | -4.37 | -6.84 | -10.34 | -8.16 | -6.64 |
Tangible Book Value Per Share | -0.40 | -0.39 | -0.88 | -1.39 | -1.31 | -1.18 |
Machinery | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |